Y42: Hormones and their synthetic substitutes and antagonists, not elsewhere classified
Y42.3: Insulin and oral hypoglycaemic [antidiabetic] drugs
The condition referred to by Y42.3 in the ICD-10 WHO 2016 classification is a reaction or adverse effect to insulin and oral hypoglycaemic (antidiabetic) drugs. These medicines are commonly used to control blood sugar levels in people with diabetes. The drugs work by helping the body's cells use glucose more efficiently or by reducing the amount of glucose produced by the liver. However, in some cases, they can lead to an oversupply of insulin, causing an individual's blood sugar to drop too low, a state known as hypoglycaemia. Symptoms of hypoglycaemia can include light-headedness, confusion, sweating, fast heartbeat, hunger, irritability, and even loss of consciousness in severe cases.
Patient Disclaimer
The information provided on this page is for general educational purposes only. It is not intended for self-diagnosis and does not replace professional medical advice. Always consult your doctor or a qualified healthcare provider with any questions or concerns about your health.
If you see an ICD diagnosis code (e.g., on a medical report), be aware that doctors may also include additional indicators to express diagnostic certainty. Only a healthcare professional can interpret these codes accurately in the context of your individual case.
For a complete understanding of your condition and what the diagnosis means for you, please speak directly with your doctor.